MRVI — Maravai Lifesciences Holdings Share News
0.000.00%
Last trade - 00:00- $1.84bn
- $2.09bn
- $185.74m
Brief: Trilink Biotechnologies Announces Manufacturing Capabilities Expansion As mRNA Manufacturing Facility Nears Completion
Vaccine reagent vendor Maravai draws private equity interest-sources
U.S. STOCKS ON THE MOVE-Airbnb, Y-mAbs Therapeutics, Neuronetics
U.S. STOCKS ON THE MOVE-Boeing, TScan Therapeutic, Under Armour
U.S. STOCKS ON THE MOVE-Alto Ingredients, Squarespace, Palantir
U.S. STOCKS ON THE MOVE-ClearOne, Coty, Novavax
Maravai LifeSciences down on trimming 2023 sales, profit forecasts
Brief: Maravai Lifesciences Reports First Quarter 2023 Financial Results
Maravai LifeSciences Holdings Inc reports results for the quarter ended in March - Earnings Summary
Brief: Maravai LifeSciences Sees FY revenue USD 400-440 million
Maravai LifeSciences Holdings Inc expected to post earnings of 4 cents a share - Earnings Preview
Brief: Maravai Lifesciences Holdings Inc - Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank
Maravai LifeSciences Holdings Inc reports results for the quarter ended in December - Earnings Summary
Maravai LifeSciences Holdings Inc expected to post earnings of 34cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Autozone, Nike, Sachem Capital
Brief: Maravai Lifesciences Announces Updated CEO Leadership Transition Plans
Brief: Maravai Lifesciences Reports Third Quarter 2022 Results
Maravai LifeSciences Holdings Inc reports results for the quarter ended in September - Earnings Summary
Maravai LifeSciences Holdings Inc expected to post earnings of 33cents a share - Earnings Preview